These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10481973)

  • 21. Serum lipoprotein (a) levels in patients with chronic renal failure--evolution after renal transplantation and relationship with other parameters of lipoprotein metabolism: a prospective study.
    Segarra A; Chacón P; Martin M; Vilardell M; Vila J; Cotrina M; Fort J; Olmos A; Piera LL
    Nephron; 1995; 69(1):9-13. PubMed ID: 7891807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Methods of biochemical analysis in hyperliproproteinemias].
    Fruchart JC; Clavey V; Vanhoutte G
    Pathol Biol (Paris); 1983 Apr; 31(4):235-45. PubMed ID: 6408590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.
    Samuelsson O; Attman PO; Knight-Gibson C; Kron B; Larsson R; Mulec H; Weiss L; Alaupovic P
    Nephron; 1997; 75(3):286-94. PubMed ID: 9069450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hyperlipoproteinemias.
    Patsch W; Patsch JR; Gotto AM
    Med Clin North Am; 1989 Jul; 73(4):859-93. PubMed ID: 2657266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes in serum lipid and lipoprotein levels in patients with chronic uremia during hemodialysis treatment].
    László A; Csalánosiné Németh M; Joó I; Kiss E; Havass Z; Szenohradszki P
    Orv Hetil; 1986 May; 127(19):1129-31. PubMed ID: 3714258
    [No Abstract]   [Full Text] [Related]  

  • 27. Lipid and lipoprotein abnormalities in children on hemodialysis and after renal transplantation.
    Van Gool S; Van Damme-Lombaerts R; Cobbaert C; Proesmans W; Eggermont E
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1375-7. PubMed ID: 1989241
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of a lipid-lowering diet on lipids, lipoproteins and apolipoproteins in the serum].
    Mertz DP; Göhmann E; Ostertag J
    Med Welt; 1982 Sep; 33(38):1302-5. PubMed ID: 7132690
    [No Abstract]   [Full Text] [Related]  

  • 29. Severe type III hyperlipoproteinemia in two patients maintained on chronic hemodialysis.
    Feussner G; Bommer J; Ziegler R
    Klin Wochenschr; 1990 Jan; 68(2):65-70. PubMed ID: 2319734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lipids, lipoproteins, apoproteins and clinical arteriopathic manifestations].
    Rouffy J; Chanu B; Bakir R; Goy-Loeper J; Miro I
    Pathol Biol (Paris); 1983 Apr; 31(4):261-70. PubMed ID: 6346239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes in HDL-cholesterol, subfractions HDL2 and HDL3 and apo-A, apo-A1 and apo-B lipoproteins in patients with chronic renal failure subjected to maintenance hemodialysis].
    Scarazatti E; Garavaglia G
    Boll Soc Ital Biol Sper; 1985 Jan; 61(1):15-21. PubMed ID: 3977994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
    Attman PO; Alaupovic P; Tavella M; Knight-Gibson C
    Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluvastatin for dyslipoproteinemia, with or without concomitant chronic renal insufficiency.
    Lintott CJ; Scott RS; Bremer JM; Shand BI
    Am J Cardiol; 1995 Jul; 76(2):97A-101A. PubMed ID: 7604809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atherogenic lipid profile and lipoprotein(a) in relation to serum albumin in haemodialysis patients.
    Yang WS; Kim SB; Min WK; Park S; Lee MS; Park JS
    Nephrol Dial Transplant; 1995; 10(9):1668-71. PubMed ID: 8559487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Less well-known lipid "risk" factors of arteriosclerosis].
    Pagnan A; Zanetti G; Guarini P; Dal Palú C
    G Clin Med; 1980 Aug; 61(8):593-600. PubMed ID: 7004983
    [No Abstract]   [Full Text] [Related]  

  • 36. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency.
    Samuelsson O; Mulec H; Knight-Gibson C; Attman PO; Kron B; Larsson R; Weiss L; Wedel H; Alaupovic P
    Nephrol Dial Transplant; 1997 Sep; 12(9):1908-15. PubMed ID: 9306342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lipoprotein (a) in children with chronic renal failure treated conservatively].
    Zwolińska D; Kiliś-Pstrusińska K; Szprynger K
    Pol Merkur Lekarski; 1997 Sep; 3(15):126-8. PubMed ID: 9461709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative abnormalities of lipoprotein particles in chronic hemodialysis patients.
    Parra HJ; Cachera C; Equagoo K; Dracon M; Fruchart JC; Tacquet A
    Adv Exp Med Biol; 1988; 243():283-7. PubMed ID: 3223421
    [No Abstract]   [Full Text] [Related]  

  • 39. Total antioxidant capacity (TAC): is it an effective method to evaluate the oxidative stress in uraemia?
    Bergesio F; Monzani G; Ciuti R; Pinzani P; Fiaschi N; Priami F; Cirami C; Ciccarelli C; Salvadori M
    J Biolumin Chemilumin; 1998; 13(5):315-9. PubMed ID: 9839198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.